Enhanced surveillance of newly acquired hepatitis C virus infection in Canada, 1998 to 2004

Scandinavian Journal of Infectious Diseases

Volumn 38, Issue 6-7, 2006, Pages 482-489

  Wu, Hong Xing ^a   Wu, Jun ^a   Wong, Tom ^a   Donalson, Tracey ^a   Dinner, Katherine ^a   Andonov, Anton ^b   Ip Chan, Jessica ^c   Moffat, Barbara ^d   Baptiste, Beverley ^e   Furseth, Janet ^f   Poliquin, Darlene ^g   Bolesnikov, Grlica ^h   Giulivi, Antonio ^a   Paton, Shirley ^a  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b Public Health Agency of Canada   (Canada)

^c VANCOUVER COASTAL HEALTH   (Canada)

^d BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

^e Capital Health Edmonton   (Canada)

^f CALGARY HEALTH REGION   (Canada)

^g Public Health and Long Term Care Branch   (Canada)

^h NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CANADA; CHILD; CONTROLLED STUDY; DATA COLLECTION METHOD; DEMOGRAPHY; DISEASE SURVEILLANCE; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INCIDENCE; INFANT; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; STANDARDIZATION; TREND STUDY; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AGED; CANADA; CHILD; CHILD, PRESCHOOL; EPIDEMIOLOGIC METHODS; FEMALE; HEPATITIS C; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; POPULATION SURVEILLANCE;

EID: 33746602214     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540500525161     Document Type: Article

References (21)

1. Pohani, G and Zou, S and Tepper, M. (2001) Trends of hepatitis B and hepatitis C mortality in Canada, 1979-1997 Can J Public Health, 92, pp. 250-4.
2. Remis R. A study to characterize the epidemiology of hepatitis C infection in Canada, 2002Report to Health Canada. 2002.
3. Gully, PR and Tepper, ML. (1997) Hepatitis C CMAJ, 156, pp. 1427-30.
4. Roy, E and Haley, N and Leclerc, P and Boivin, JF and Cedras, L and Vincelette, J. (2001) Risk factors for hepatitis C virus infection among street youths CMAJ, 165, pp. 557-60.
5. Patrick, DM and Tyndall, MW and Cornelisse, PG and Li, K and Sherlock, CH and Rekart, ML and (2001) Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection CMAJ, 165, pp. 889-95.
6. Bowker, SL and Soskolne, CL and Houston, SC and Newman, SC and Jhangri, GS. (2004) Human immunodeficiency virus (HIV) and hepatitis C virus (HCV) in a northern Alberta population Can J Public Health, 95, pp. 188-92.
7. Alter, MJ and Seeff, LB and Bacon, BR and Thomas, DL and Rigsby, MO and Di Bisceglie, AM. (2004) Testing for hepatitis C virus infection should be routine for persons at increased risk for infection Ann Intern Med, 141, pp. 715-7.
8. Goldberg, D and Anderson, E. (2004) Hepatitis C: Who is at risk and how do we identify them? J Viral Hepat, 11((Suppl 1)), pp. S12-8.
9. Sockett, PN and Garnett, MJ and Scott, C. (1996) Communicable disease surveillance: Notification of infectious disease in Canada Can J Infect Dis, 7, pp. 293-5.
10. Zou, S and Zhang, J and Tepper, M and Giulivi, A and Baptiste, B and Predy, G and (2001) Enhanced surveillance of acute hepatitis B and C in 4 regions in Canada, 1998 to 1999 Can J Infect Dis, 12, pp. 357-63.
11. Alter, MJ. (1989) Non-A, non-B hepatitis: Sorting through a diagnosis of exclusion Ann Intern Med, 110, pp. 583-5.
12. Chiavetta, JA and Escobar, M and Newman, A and He, Y and Driezen, P and Deeks, S and (2003) Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1991-2000 CMAJ, 169, pp. 767-73.
13. Alter, MJ. (1999) Hepatitis C virus infection in the United States J Hepatol, 31(Suppl 1), pp. S88-91.
14. Ramsay, ME and Balogun, MA and Collins, M and Balraj, V. (1998) Laboratory surveillance of hepatitis C virus infection in England and Wales: 1992 to 1996 Commun Dis Public Health, 1, pp. 89-94.
15. Jaeckel, E and Cornberg, M and Wedemeyer, H and Santantonio, T and Mayer, J and Zankel, M and (2001) Treatment of acute hepatitis C with interferon alfa-2b N Engl J Med, 345, pp. 1452-7.
16. Dore, GJ and Law, MG and Kaldor, JM. (1999) Prevalence of hepatitis C virus infection in the United States N Engl J Med, 341, pp. 2093-4.
17. Terrault, NA. (2002) Sexual activity as a risk factor for hepatitis C Hepatology., 36(Suppl. 1), pp. S99-105.
18. Balogun, MA and Ramsay, ME and Parry, JV and Donovan, L and Andrews, NJ and Newham, JA and (2003) A national survey of genitourinary medicine clinic attenders provides little evidence of sexual transmission of hepatitis C virus infection Sex Transm Infect, 79, pp. 301-6.
19. Nieuwenhuis, RF and Ossewaarde, JM and Götz, HM and Dees, J and Thio, HB and Maarten Thomeer, MG and (2004) Resurgence of lymphogranuloma venereum in Western Europe: An outbreak of Chlamydia trachomatis serovar l2 proctitis in the Netherlands among men who have sex with men Clin Infect Dis, 39, pp. 996-1003.
20. Kropp RY WongT, Canadian LGV Working Group. Emergence of lymphogranuloma venereum in Canada CMAJ 2005;172:1674-6.
21. Götz, HM and van Doornum, G and Niesters, HG and den Hollander, JG and Thio, HB and de Zwart, O. (2005) A cluster of acute hepatitis C virus infection among men who have sex with men: Results from contact tracing and public health implications AIDS, 19, pp. 969-74.